![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Bora Pharmaceuticals completes the acquisition of Upsher-Smith
Bora Pharmaceuticals Co., Ltd announced that it has completed the acquisition of Upsher-Smith Laboratories, Inc....
Continuous Bioprocessing Shapes Biopharma Manufacturing
The biopharmaceutical industry happens to be experiencing a massive shift toward continuous bioprocessing. Unlike traditional...
Biotherapeutic Drug Creation – Analytics, Mass Spec Lay Path
In the modern era, biopharmaceutical discovery and development scientists happen to be achieving new levels...
Equitable Access In Pandemics – Biopharma Steps Up Its Worth
The 77th World Health Assembly- WHA goes on to mark the deadline for the conclusion...
Exothera pledges to fast-track RNA therapies with expansion of world-first continuous-batch RNA manufacturing solution...
Belgium-headquartered Exothera, a leading provider of nucleic acids and viral vector development and manufacturing services,...
Drug Wars Continue Despite Registry Patent Listing Crackdown
No company happened to be hit harder by the US Federal Trade Commission’s crackdown when...
Hovione and GEA Strengthen Partnership to Advance Continuous Tableting Technology
Hovione, the specialist integrated CDMO and leader in spray drying and particle engineering, and GEA,...
ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients...
ReciBioPharm, the advanced and emerging therapies business unit of Recipharm, has announced a collaboration agreement...
Platform Tech For Cell & Gene Therapy Processing Scale-Up
Robust trend has been seen to invest in platform technologies, both in numbers and deal...
Berry’s Dual Chamber Inhaler Enables Access to Combination Drugs
Berry Global, a leader in the design, development, and production of patient-centred healthcare solutions, recently...